过表达SIRT4对骨肉瘤细胞恶性生物学行为及能量代谢的影响

岳小涵, 康权, 石雨鹭, 罗庆

PDF(6995 KB)
PDF(6995 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (08) : 949-958. DOI: 10.13406/j.cnki.cyxb.003560
基础研究

过表达SIRT4对骨肉瘤细胞恶性生物学行为及能量代谢的影响

作者信息 +

Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells

Author information +
History +

摘要

目的 探讨过表达SIRT4对人骨肉瘤细胞恶性生物学行为及对成骨分化的调控作用,以及过表达SIRT4对线粒体能量代谢的影响。 方法 构建稳定过表达SIRT4的U2OS、MG63骨肉瘤细胞株,通过qRT-PCR和Western blot检测SIRT4的mRNA和蛋白表达水平;CCK-8、克隆形成实验、EDU555染色法及检测细胞增殖;裸鼠胫骨成瘤实验检验成瘤能力;流式细胞术检测细胞周期;DAPI染色及Annexin V-APC/7-AAD双染法检测细胞凋亡;细胞划痕实验、Transwell实验检测细胞迁移及侵袭能力;碱性磷酸酶(alkaline phosphatase,ALP)染色和茜素红S染色分别检测细胞的早期和晚期成骨分化;葡萄糖检测试剂盒测定培养基及细胞内葡萄糖含量;乳酸检测试剂盒测定培养基及细胞内乳酸含量;三磷酸腺苷(adenosine triphosphate,ATP)检测试剂盒检测细胞总ATP含量;四甲基罗丹明酯染色(tetramethylrhodamine ethylester perchlorate,TMRE)测定试剂检测线粒体膜电位。 结果 过表达SIRT4组细胞增殖、迁移及侵袭能力降低,裸鼠胫骨成瘤的瘤体体积减小,凋亡细胞增多;过表达SIRT4组细胞的G0/G1期占比明显增多,S期占比明显减少;过表达SIRT4组细胞ALP染色、茜素红S染色钙盐结节明显增多;过表达SIRT4组培养基中的葡萄糖较对照组消耗减少,细胞中的葡萄糖含量较对照组减少;过表达SIRT4组细胞中的乳酸含量较对照组减少,培养基中的乳酸较对照组产生减少;过表达SIRT4组细胞的总ATP较对照组更低;过表达SIRT4组的线粒体膜电位较对照组更低。 结论 在U2O和MG63细胞中,过表达SIRT4抑制骨肉瘤细胞增殖、迁移、侵袭以及成瘤能力,促进骨肉瘤细胞凋亡以及早晚期成骨分化,调节骨肉瘤细胞能量代谢。

Abstract

Objective To investigate the regulatory effect of sirtuin 4 (SIRT4) overexpression on the malignant biological behavior of human osteosarcoma cells and osteogenic differentiation,as well as the influence of SIRT4 overexpression on mitochondrial energy metabolism. Methods U2OS and MG63 osteosarcoma cell lines with stable overexpression of SIRT4 were constructed,and qRT-PCR and Western blot were used to measure the mRNA and protein expression levels of SIRT4;CCK-8 assay,colony formation assay,and EDU555 staining were used to observe cell proliferation;tibial tumorigenesis assay in nude mice was used to observe tumorigenic ability;flow cytometry was used to detect cell cycle;DAPI staining and Annexin V-APC/7-AAd double staining were used to measure cell apoptosis;wound healing assay and Transwell assay were used to observe the migration and invasion abilities of cells;alkaline phosphatase(ALP) staining and alizarin red S staining were used to detect early and late osteogenic differentiation,respectively;glucose assay kit was used to determine the content of glucose in the medium and cells;lactic acid assay kit was used to determine the content of lactic acid in the medium and cells;triphosphate assay kit was used to determine the total content of adenosine triphosphate(ATP) in the medium and cells;tetramethylrhodamine ethyl ester perchlorate staining was used to measure mitochondrial membrane potential. Results The SIRT4 overexpression group had significant reductions in the proliferation,migration,and invasion abilities of cells,a significant reduction in the tumor volume of tibial osteoblastoma in nude mice,and a significant increase in apoptotic cells. As for cell cycle,the SIRT4 overexpression group showed a significant increase in the proportion of cells in G0/G1 phase and a significant reduction in the proportion of cells in S phase. ALP staining and alizarin red S staining showed a significant increase in the number of calcium salt nodules in the SIRT4 overexpression group. Compared with the control group,the SIRT4 overexpression group had significant reductions in the consumption of glucose in the medium and the content of glucose in cells,as well as significant reductions in the content of lactic acid in cells and the medium. The SIRT4 overexpression group had a lower mitochondrial membrane potential than the control group. Conclusion In U2O and MG63 cells,SIRT4 overexpression inhibits the proliferation,migration,invasion,and tumorigenic ability of osteosarcoma cells,promotes the apoptosis of osteosarcoma cells and early and late osteogenic differentiation,and regulates energy metabolism in osteosarcoma cells.

关键词

骨肉瘤 / SIRT4 / 恶性生物学行为 / 成骨分化 / 能量代谢

Key words

osteosarcoma / sirtuin 4 / malignant biological behavior / osteogenic differentiation / energy metabolism

中图分类号

R114

引用本文

导出引用
岳小涵 , 康权 , 石雨鹭 , . 过表达SIRT4对骨肉瘤细胞恶性生物学行为及能量代谢的影响. 重庆医科大学学报. 2024, 49(08): 949-958 https://doi.org/10.13406/j.cnki.cyxb.003560
Yue Xiaohan, Kang Quan, Shi Yulu, et al. Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells[J]. Journal of Chongqing Medical University. 2024, 49(08): 949-958 https://doi.org/10.13406/j.cnki.cyxb.003560

参考文献

1
Cho WH Song WS Jeon DG,et al. Differential presentations,clinical courses,and survivals of osteosarcomas of the proximal humerus over other extremity locations[J]. Ann Surg Oncol201017(3):702-708.
2
Cole S Gianferante DM Zhu B,et al. Osteosarcoma:a Surveillance,Epidemiology,and End Results program-based analysis from 1975 to 2017[J]. Cancer2022128(11):2107-2118.
3
Hanahan D Weinberg RA. Hallmarks of cancer:the next generation[J].Cell2011144(5):646-674.
4
Zhu YM Yan YF Principe DR,et al. SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis[J]. Cancer Metab20142:15.
5
Haigis MC Mostoslavsky R Haigis KM,et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells[J]. Cell2006126(5):941-954.
6
Laurent G German NJ Saha AK,et al. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase[J]. Mol Cell201350(5):686-698.
7
Huang GY Cheng J Yu FD,et al. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer[J]. Oncol Rep201635(5):2801-2810.
8
Jeong SM Xiao CY Finley LW,et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism[J]. Cancer Cell201323(4):450-463.
9
Wan W Li YN Zhou CY,et al. SIRT4 expression in laryngeal squamous cell carcinoma[J]. Pharmazie202075(12):646-650.
10
Jeong SM Lee AN Lee J,et al. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma[J]. J Biol Chem2014289(7):4135-4144.
11
Cai GH Ge ZH Xu YQ,et al. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism[J]. Sci Rep202212(1):12208.
12
Zhu YY Wang GY Li XB,et al. Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells[J]. Oncol Lett201816(2):1675-1681.
13
Xing JL Li J Fu L,et al. SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway[J]. Cancer Med20198(16):7086-7097.
14
Delgrosso E Scocozza F Cansolino L,et al. 3D bioprinted osteosarcoma model for experimental boron neutron capture therapy (BNCT) applications:preliminary assessment[J]. J Biomed Mater Res B Appl Biomater2023111(8):1571-1580.
15
Brown HK Schiavone K Gouin F,et al. Biology of bone sarcomas and new therapeuticdevelopments[J]. Calcif Tissue Int2018102(2):174-195.
16
Dong ZH Liao ZP He YL,et al. Advances in the biological functions and mechanisms of miRNAs in the development of osteosarcoma[J]. Technol Cancer Res Treat202221:15330338221117386.
17
Xie DL Wang ZQ Li J,et al. Targeted delivery of chemotherapeutic agents for osteosarcoma treatment[J]. Front Oncol202212:843345.
18
Panez-Toro I Muñoz-García J Vargas-Franco JW,et al. Advances in osteosarcoma[J]. Curr Osteoporos Rep202321(4):330-343.
19
Huang H Han Y Chen ZJ,et al. ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β-catenin signalling pathways[J]. J Cell Mol Med202024(10):5652-5664.
20
Zhu WT Zeng XF Yang H,et al. Resveratrol loaded by folate-modified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2/STAT3 pathway[J]. Int J Nanomed202318: 2677-2691.
21
Wu W Zhang ZH Jing DD,et al. SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma[J]. Cell Death Dis202213(6):523.
22
Zhao S Wang JM Yan J,et al. BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase[J]. Cell Death Dis201910(4):284.
23
Yalçın GD Colak M. SIRT4 prevents excitotoxicity via modulating glutamate metabolism in glioma cells[J]. Hum Exp Toxicol202039(7):938-947.
24
Cui Y Bai YB Yang JN,et al. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway[J]. Carcinogenesis202142(3):481-492.
25
Hu QS Qin Y Ji SR,et al. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer[J]. Cancer Lett2019452:226-236.
26
Ping DN Pu XF Ding GP,et al. Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex[J]. Biochim Biophys Acta Gene Regul Mech20231866(2):194941.
27
Wang YM Guo YM Gao JZ,et al. Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage[J]. Cancer Manag Res201810:5591-5603.
28
仇 超,康 权,迭小红,等. Id1基因对人骨肉瘤细胞恶性逆转向成骨分化的影响[J]. 第三军医大学学报201638(4):344-349.
Qiu C Kang Q Die XH,et al. Effect of Id1 gene on reversing malignant biological behaviors and inducing osteogenic differentiation of human osteosarcoma cells[J]. J Third Mil Med Univ201638(4):344-349.
29
Roschger C Cabrele C. The Id-protein family in developmental and cancer-associated pathways[J]. Cell Commun Signal201715(1):7.
30
Singh SK Singh S Gadomski S,et al. Id1 ablation protects hematopoietic stem cells from stress-induced exhaustion and aging[J]. Cell Stem Cell201823(2):252-265.
31
Lin ZK Liu Y Xu T,et al. STAT3-mediated promoter-enhancer interaction up-regulates inhibitor of DNA binding 1(ID1) to promote colon cancer progression[J]. Int J Mol Sci202324(12):10041.
32
Sharma BK Kolhe R Black SM,et al. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells[J]. FASEB J201630(1):262-275.
33
Xu X Hou YQ Lin SM,et al. Sodium selenite inhibits proliferation of lung cancer cells by inhibiting NF-κB nuclear translocation and down-regulating PDK1 expression which is a key enzyme in energy metabolism expression[J]. J Trace Elem Med Biol202378:127147.
34
Xing BY Shen CY Yang QL,et al. miR-144-3p represses hepatocellular carcinoma progression by affecting cell aerobic glycolysis via FOXK1[J]. Int J Exp Pathol2023104(3):117-127.
35
Kimura K Chun JH Lin YL,et al. Tetra-O-methyl-nordihy-droguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets[J]. PLoS One202318(5):e0285536.
36
Weng YP Duan WH Yu XC,et al. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis[J]. Cancer Sci2023114(6):2345-2359.
37
Mathias RA Greco TM Oberstein A,et al. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity[J]. Cell2014159(7):1615-1625.

基金

国家自然科学基金资助项目(81172545)
重庆市自然科学基金资助项目(cstc2020jcyj-msxmX0113)

评论

PDF(6995 KB)

Accesses

Citation

Detail

段落导航
相关文章

/